K. Tamai

发表

Rapid transport of plasmid DNA into the nucleolus via actin depolymerization using the HVJ envelope vector

Y. Kaneda, S. Suvanasuthi, K. Tamai, 2007, The journal of gene medicine.

Chromatin accessibility identifies diversity in mesenchymal stem cells from different tissue origins

Y. Kaneda, K. Tamai, Eiichi Takaki, 2018, Scientific Reports.

Transcriptionally distinct mesenchymal stem/stromal cells circulate in fetus.

Y. Kaneda, Tadashi Kimura, K. Tamai, 2019, Biochemical and biophysical research communications.

PDGFRα-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia

Y. Kaneda, J. Miyazaki, M. Ishii, 2011, Proceedings of the National Academy of Sciences.

In vivo gene introduction into keratinocytes using jet injection

K. Tamai, I. Hashimoto, K. Hanada, 1999, Gene Therapy.

Physician‐initiated first‐in‐human clinical study using a novel angiogenic peptide, AG30/5C, for patients with severe limb ulcers

Y. Kaneda, H. Rakugi, Y. Takeya, 2017, Geriatrics & gerontology international.

Cell-specific Induction of Distinct Oncogenes of the Jun Family Is Responsible for Differential Regulation of Collagenase Gene Expression by Transforming Growth Factor- in Fibroblasts and Keratinocytes (*)

J. Uitto, K. Tamai, A. Mauviel, 1996, The Journal of Biological Chemistry.

Microbubble-enhanced ultrasound for gene transfer into living skin equivalents.

Y. Kaneda, K. Sayama, Y. Hanakawa, 2005, Journal of dermatological science.

Comparative roles of Twist-1 and Id1 in transcriptional regulation by BMP signaling

Y. Kaneda, H. Kato, K. Takaoka, 2007, Journal of Cell Science.

Transplanted Bone Marrow–Derived Circulating PDGFRα+ Cells Restore Type VII Collagen in Recessive Dystrophic Epidermolysis Bullosa Mouse Skin Graft

Y. Kaneda, M. Ishii, J. Uitto, 2015, The Journal of Immunology.

Contribution of PDGFRα lineage cells in adult mouse hematopoiesis.

K. Tamai, Eiichi Takaki, T. Shimbo, 2020, Biochemical and biophysical research communications.

Cross-talk between bone marrow mesenchymal stem cells and injured tissue

K. Tamai, 2016 .

Stem Cell Therapy for Epidermolysis Bullosa-Does It Work?

J. Uitto, K. Tamai, 2016, The Journal of investigative dermatology.

Cinnamtannin B-1 Promotes Migration of Mesenchymal Stem Cells and Accelerates Wound Healing in Mice

Y. Kaneda, Y. Takenaka, T. Tanahashi, 2015, PloS one.

Stem Cells , Tissue Engineering and Hematopoietic Elements Bone Marrow Cell Transfer into Fetal Circulation Can Ameliorate Genetic Skin Diseases by Providing Fibroblasts to the Skin and Inducing Immune Tolerance

Y. Kaneda, J. Uitto, Satoru Otsuru, 2010 .

Prevention and regression of atopic dermatitis by ointment containing NF-kB decoy oligodeoxynucleotides in NC/Nga atopic mouse model

M. Aoki, T. Ogihara, Y. Kaneda, 2002, Gene Therapy.

Novel Autologous Cell Therapy in Ischemic Limb Disease Through Growth Factor Secretion by Cultured Adipose Tissue–Derived Stromal Cells

Tomoyuki Nishikawa, Ryuichi Morishita, Toshio Ogihara, 2005, Arteriosclerosis, thrombosis, and vascular biology.

Modification of a novel angiogenic peptide, AG30, for the development of novel therapeutic agents

Y. Kaneda, R. Morishita, H. Nakagami, 2012, Journal of cellular and molecular medicine.

Development of a novel antimicrobial peptide, AG-30, with angiogenic properties

Y. Kaneda, R. Morishita, Y. Tabata, 2008, Journal of cellular and molecular medicine.

Transfection of Human Hepatocyte Growth Factor Gene Ameliorates Secondary Lymphedema via Promotion of Lymphangiogenesis

Y. Kaneda, R. Morishita, H. Nakagami, 2006 .

Transfection of Human Hepatocyte Growth Factor Gene Ameliorates Secondary Lymphedema via Promotion of Lymphangiogenesis

Y. Kaneda, R. Morishita, H. Nakagami, 2006, Circulation.

Development of high-throughput functional screening of therapeutic genes, using a hemagglutinating virus of Japan envelope vector.

Tomoyuki Nishikawa, Ryuichi Morishita, Yasufumi Kaneda, 2006, Human gene therapy.

FHL-2 Suppresses VEGF-Induced Phosphatidylinositol 3-Kinase/Akt Activation via Interaction With Sphingosine Kinase-1

Y. Kaneda, R. Morishita, H. Nakagami, 2009, Arteriosclerosis, thrombosis, and vascular biology.

Development of a transferrin receptor-targeting HVJ-E vector.

Y. Kaneda, K. Tamai, T. Shimbo, 2007, Biochemical and biophysical research communications.

No influence of tumor growth by intramuscular injection of hepatocyte growth factor plasmid DNA: safety evaluation of therapeutic angiogenesis gene therapy in mice.

M. Aoki, T. Ogihara, Y. Kaneda, 2004, Biochemical and biophysical research communications.

Development of tissue-targeting hemagglutinating virus of Japan envelope vector for successful delivery of therapeutic gene to mouse skin.

Y. Kaneda, J. Uitto, M. Amagai, 2007, Human gene therapy.

Biocompatible polymer enhances the in vitro and in vivo transfection efficiency of HVJ envelope vector

Y. Kaneda, Y. Tabata, Seiji Yamamoto, 2005, The journal of gene medicine.

Enhanced Tumor-Specific Long-Term Immunity of Hemaggluttinating Virus of Japan-Mediated Dendritic Cell-Tumor Fused Cell Vaccination by Coadministration with CpG Oligodeoxynucleotides1

K. Hiraoka, T. Ogihara, Y. Kaneda, 2004, The Journal of Immunology.

Intrathecal injection of HVJ‐E containing HGF gene to cerebrospinal fluid can prevent and ameliorate hearing impairment in rats

Y. Kaneda, R. Morishita, S. Mizuno, 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Needleless intranasal administration of HVJ-E containing allergen attenuates experimental allergic rhinitis

Yasufumi Kaneda, Takeshi Kubo, Y. Kaneda, 2007, Journal of Molecular Medicine.

Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice.

Hideki Yoshikawa, Yasufumi Kaneda, Y. Kaneda, 2007, Biochemical and biophysical research communications.

Rad51 siRNA delivered by HVJ envelope vector enhances the anti‐cancer effect of cisplatin

Yasufumi Kaneda, K. Hiraoka, Y. Kaneda, 2005, The journal of gene medicine.

Circulating Bone Marrow‐Derived Osteoblast Progenitor Cells Are Recruited to the Bone‐Forming Site by the CXCR4/Stromal Cell‐Derived Factor‐1 Pathway

Hideki Yoshikawa, Yasufumi Kaneda, Y. Kaneda, 2008, Stem cells.

Systemic high-mobility group box 1 administration suppresses skin inflammation by inducing an accumulation of PDGFRα+ mesenchymal cells from bone marrow

Y. Kaneda, R. Fujita, K. Tamai, 2015, Scientific Reports.

Controlled release of bone morphogenetic protein-2 enhances recruitment of osteogenic progenitor cells for de novo generation of bone tissue.

Yasuhiko Tabata, Yu Kimura, Yasufumi Kaneda, 2010, Tissue engineering. Part A.

Targeted chemotherapy against intraperitoneally disseminated colon carcinoma using a cationized gelatin–conjugated HVJ envelope vector

Yasuhiko Tabata, Yasufumi Kaneda, Y. Kaneda, 2006, Molecular Cancer Therapeutics.

High-mobility group box 1 fragment suppresses adverse post-infarction remodeling by recruiting PDGFRα-positive bone marrow cells

S. Miyagawa, Y. Sawa, K. Tamai, 2020, PloS one.

A homozygous missense mutation in the cytoplasmic tail of beta4 integrin, G931D, that disrupts hemidesmosome assembly and underlies Non-Herlitz junctional epidermolysis bullosa without pyloric atresia?

H. Shimizu, J. McGrath, T. Hashimoto, 2000, The Journal of investigative dermatology.

Generation of a recessive dystrophic epidermolysis bullosa mouse model with patient-derived compound heterozygous mutations

K. Tamai, T. Shimbo, T. Kitayama, 2022, Laboratory Investigation.

Cut-C: cleavage under tethered nuclease for conformational capture

Y. Kaneda, K. Tamai, Eiichi Takaki, 2019, BMC Genomics.

Induction of keratinocyte proliferation and lymphocytic infiltration by in vivo introduction of the IL-6 gene into keratinocytes and possibility of keratinocyte gene therapy for inflammatory skin diseases using IL-6 mutant genes.

K. Tamai, I. Hashimoto, K. Hanada, 1998, Journal of immunology.

Using IL-6 Mutant Genes Gene Therapy for Inflammatory Skin Keratinocytes and Possibility of Keratinocyte Introduction of the IL-6 Gene into Lymphocytic Infiltration by In Vivo Induction of Keratinocyte Proliferation

K. Tamai, I. Hashimoto, K. Hanada, 1998 .

Interleukin-10 modulates type I collagen and matrix metalloprotease gene expression in cultured human skin fibroblasts.

J. Uitto, A. Remitz, K. Tamai, 1994, The Journal of clinical investigation.

Role of cysteine residues in the activity of rat glutathione transferase P (7-7): elucidation by oligonucleotide site-directed mutagenesis.

A. Yasui, S. Tsuchida, K. Tamai, 1991, Biochemical and biophysical research communications.

Specific inactivation of glutathione S-transferases in class Pi by SH-modifiers.

S. Tsuchida, K. Tamai, K. Sato, 1990, Biochemical and Biophysical Research Communications - BBRC.

Transient induction of single GST-P positive hepatocytes by DEN.

T. Shimizu, M. Tatematsu, K. Tamai, 1989, Carcinogenesis.

Specific expression of glutathione S-transferase Pi forms in (pre)neoplastic tissues: their properties and functions.

S. Tsuchida, K. Tamai, Y. Yamada, 1992, The Tohoku journal of experimental medicine.

18 – PROPERTIES AND FUNCTIONS OF NEUTRAL AND ACIDIC GLUTATHIONE S-TRANSFERASES1

T. Ishikawa, S. Tsuchida, K. Tamai, 1989 .

Expression of glutathione S-transferase-pi in malignant skin tumors.

K. Tamai, I. Hashimoto, K. Hanada, 1991, Journal of dermatological science.

Interleukin 10 up-regulates elastin gene expression in vivo and in vitro at the transcriptional level.

J. Uitto, A. Remitz, K. Tamai, 1994, The Biochemical journal.

Dynamic changes in intracellular location of metallothionein in rat keratinocytes after ultraviolet-B irradiation.

K. Tamai, T. Muramatsu, I. Hashimoto, 1998, The Journal of investigative dermatology.

Novel Function of Metallothionein in Photoprotection: Metallothionein-Null Mouse Exhibits Reduced Tolerance Against Ultraviolet B Injury in the Skin

N. Miura, A. Naganuma, K. Tamai, 1998 .

Inhibitory effect of beta-thujaplicin on ultraviolet B-induced apoptosis in mouse keratinocytes.

K. Tamai, I. Hashimoto, D. Sawamura, 1998, The Journal of investigative dermatology.

Receptor for Advanced Glycation End Products-Mediated Signaling Impairs the Maintenance of Bone Marrow Mesenchymal Stromal Cells in Diabetic Model Mice.

Y. Kaneda, R. Fujita, K. Tamai, 2016, Stem cells and development.

Cutaneous gene delivery.

Y. Kaneda, K. Tamai, Y. Kikuchi, 2008, Journal of dermatological science.

Cloning of the mouse desmoglein 3 gene (Dsg3): interspecies conservation within the cadherin superfamily

J. Uitto, K. Tamai, D. Sawamura, 2000, Experimental dermatology.

In vivo transfer of a foreign gene to keratinocytes using the hemagglutinating virus of Japan-liposome method.

K. Tamai, K. Nomura, I. Hashimoto, 1997, The Journal of investigative dermatology.

Enhancement of ultraviolet‐induced apoptosis by NF‐κB decoy oligonucleotides

K. Tamai, K. Hanada, T. Yamazaki, 2005 .

Differential Regulation of Karyopherin α 2 Expression by TGF-β1 and IFN-γ in Normal Human Epidermal Keratinocytes: Evident Contribution of KPNA2 for Nuclear Translocation of IRF-1

Y. Kaneda, K. Tamai, I. Katayama, 2007 .

A keratin K10 gene mutation in a Japanese patient with epidermolytic hyperkeratosis

K. Tamai, K. Nomura, I. Hashimoto, 1997, Japanese Journal of Human Genetics.

A novel keratin K5 gene mutation in Dowling-Meara epidermolysis bullosa simplex.

H. Shimizu, T. Nishikawa, K. Tamai, 1996, The Journal of investigative dermatology.

Single‐cell transcriptome analysis of fractional CO2 laser efficiency in treating a mouse model of alopecia

K. Tamai, T. Shimbo, T. Kitayama, 2022, Lasers in surgery and medicine.

Involvement of the AP-1 site within the 5′-flanking region of the stromelysin-1 gene in induction of the gene expression by UVA irradiation

J. Uitto, K. Tamai, A. Mauviel, 1996, Archives of Dermatological Research.

Interferon-gamma coordinately upregulates matrix metalloprotease (MMP)-1 and MMP-3, but not tissue inhibitor of metalloproteases (TIMP), expression in cultured keratinocytes.

J. Uitto, K. Tamai, A. Mauviel, 1995, The Journal of investigative dermatology.

Consensus reclassification of inherited epidermolysis bullosa and other disorders with skin fragility

C. Bodemer, J. Uitto, J. McGrath, 2020, The British journal of dermatology.

Bone marrow transplant with post‐transplant cyclophosphamide for recessive dystrophic epidermolysis bullosa expands the related donor pool and permits tolerance of nonhaematopoietic cellular grafts

J. Wagner, J. Tolar, J. McGrath, 2019, The British journal of dermatology.

Calcineurin/NFAT-dependent regulation of 230-kDa bullous pemphigoid antigen (BPAG1) gene expression in normal human epidermal keratinocytes.

J. Uitto, K. Tamai, D. Sawamura, 2008, Journal of dermatological science.

Molecular biology of the 230-kD bullous pemphigoid antigen. Cloning of the BPAG1 gene and its tissue-specific expression.

J. Uitto, K. Tamai, D. Sawamura, 1994, Dermatology.

Molecular therapies for heritable blistering diseases.

Y. Kaneda, J. Uitto, K. Tamai, 2009, Trends in molecular medicine.

A keratin K5 mutation (Leu 463→Pro) in a family with the Weber-Cockayne type of epidermolysis bullosa simplex

K. Tamai, K. Nomura, I. Hashimoto, 1997, Archives of Dermatological Research.

The administration of high-mobility group box 1 fragment prevents deterioration of cardiac performance by enhancement of bone marrow mesenchymal stem cell homing in the delta-sarcoglycan-deficient hamster

S. Miyagawa, Y. Sawa, K. Tamai, 2018, bioRxiv.

Vitamin D 3 inhibits expression of pemphigus vulgaris antigen desmoglein 3 : Implication of a partial mechanism in the pharmacological effect of vitamin D 3 on skin diseases

K. Tamai, Y. Matsuzaki, D. Sawamura, 2022 .

Development and clinical application of regeneration-inducing HMGB1 peptide drug

K. Tamai, 2021, Japanese Journal of Thrombosis and Hemostasis.

Fluorescent Imaging Techniques of Osteoclast Precursors Tracked by Using Systemic Circulation and Bone Recruitment

Manato Kotani, M. Ishii, F. Klauschen, 2012 .

Case of epidermolytic ichthyosis with impairment of pulmonary function and exacerbated skin manifestations in a late middle‐aged adult

M. Fujimoto, T. Nomura, M. Wataya-Kaneda, 2019, The Journal of dermatology.

The human 230-kD bullous pemphigoid antigen gene (BPAG1). Exon-intron organization and identification of regulatory tissue specific elements in the promoter region.

J. Uitto, K. Tamai, D. Sawamura, 1993, The Journal of clinical investigation.

Epidermolysis Bullosa Mouse Skin Graft VII Collagen in Recessive Dystrophic Cells Restore Type + a Circulating PDGFR Derived - Transplanted Bone Marrow

Y. Kaneda, M. Ishii, J. Uitto, 2015 .

Plap-1 lineage tracing and single-cell transcriptomics reveal cellular dynamics in the periodontal ligament.

S. Ogawa, Y. Iwakura, K. Tamai, 2022, Development.

Acceleration of wound healing by combined gene transfer of hepatocyte growth factor and prostacyclin synthase with Shima Jet

Y. Taniyama, Y. Kaneda, R. Morishita, 2006, Gene Therapy.

Enhanced tumor-specific long-term immunity of hemagglutinating [correction of hemaggluttinating] virus of Japan-mediated dendritic cell-tumor fused cell vaccination by coadministration with CpG oligodeoxynucleotides.

K. Hiraoka, T. Ogihara, Y. Kaneda, 2004, Journal of immunology.

Keratinocyte gene therapy for systemic diseases. Circulating interleukin 10 released from gene-transferred keratinocytes inhibits contact hypersensitivity at distant areas of the skin.

H. Ishida, K. Tamai, I. Hashimoto, 1998, The Journal of clinical investigation.

Expression vector with DNA of bovine papilloma virus 1 for keratinocyte gene therapy.

K. Tamai, I. Hashimoto, D. Sawamura, 2000, Journal of dermatological science.

Promoter/enhancer cassettes for keratinocyte gene therapy.

J. Miyazaki, K. Tamai, K. Nomura, 1999, The Journal of investigative dermatology.

Extragenital lichen sclerosus successfully treated by topical maxacalcitol/betamethasone butyrate propionate

K. Tamai, H. Amano, S. Mori, 2020, Clinical and experimental dermatology.

cDNA cloning and chromosomal assignment of the mouse gene for desmoglein 3 (Dsg3), the pemphigus vulgaris antigen

N. Copeland, D. Gilbert, N. Jenkins, 1994, Mammalian Genome.

Epidermolysis Bullosa Glomerular Basement Membranes for an Infant With Herlitz Junctional Nephrotic Syndrome and Aberrant Expression of Laminin Isoforms in

J. Uitto, M. Nagata, K. Tamai, 2013 .

Nephrotic Syndrome and Aberrant Expression of Laminin Isoforms in Glomerular Basement Membranes for an Infant With Herlitz Junctional Epidermolysis Bullosa

J. Uitto, M. Nagata, K. Tamai, 2005, Pediatrics.

Enhanced elastin and fibrillin gene expression in chronically photodamaged skin.

J. Uitto, R. Tuan, K. Tamai, 1994, The Journal of investigative dermatology.

Transgenic TNF-α causes apoptosis in epidermal keratinocytes after subcutaneous injection of TNF-α DNA plasmid

K. Tamai, I. Hashimoto, K. Hanada, 1999 .

Transgenic TNF-alpha causes apoptosis in epidermal keratinocytes after subcutaneous injection of TNF-alpha DNA plasmid.

K. Ita, K. Tamai, I. Hashimoto, 1999, The Journal of investigative dermatology.

Cloning of partial cDNA for mouse 180-kDa bullous pemphigoid antigen (BPAG2), a highly conserved collagenous protein of the cutaneous basement membrane zone.

J. Uitto, K. Tamai, D. Sawamura, 1992, The Journal of investigative dermatology.

Cloning of the Gene for Human Pemphigus Vulgaris Antigen (Desmoglein 3), a Desmosomal Cadherin

J. Uitto, A. Christiano, K. Tamai, 1996, The Journal of Biological Chemistry.

Mouse 230-kDa bullous pemphigoid antigen gene: structural and functional characterization of the 5'-flanking region and interspecies conservation of the deduced amino-terminal peptide sequence of the protein.

J. Uitto, K. Tamai, K. Nomura, 1994, The Journal of investigative dermatology.

Superficial Granulomatous Pyoderma: A Case Report of Two Japanese Patients and Clinical Comparison with Foreign Patients

K. Tamai, K. Hanada, T. Yamazaki, 2003, The Journal of dermatology.

Significance of sentinel node biopsy in the management of squamous cell carcinoma arising from recessive dystrophic epidermolysis bullosa

K. Tamai, Y. Matsuzaki, D. Sawamura, 2008, The Journal of dermatology.

Diagnostic dilemma of “sporadic” cases of dystrophic epidermolysis bullosa: a new dominant or mitis recessive mutation?

J. Uitto, K. Tamai, I. Hashimoto, 1999, Experimental dermatology.

Particular mutations in exon 85 of type VII collagen gene (COL7A1) induce severe itch : Specific glycine substitutions for dominant forms of epidermolysis bullosa pruriginosa

J. Uitto, K. Tamai, K. Nomura, 1998 .

Current topics in Epidermolysis bullosa: Pathophysiology and therapeutic challenges.

J. McGrath, K. Tamai, K. Natsuga, 2021, Journal of dermatological science.

Severe Palmo‐Plantar Hyperkeratosis in Koebner Epidermolysis Bullosa Simplex

K. Sayama, Y. Shirakata, S. Tokumaru, 2003, The Journal of dermatology.

Interleukin-1 induces collagenase production by recessive dystrophic epidermolysis bullosa fibroblasts

K. Tamai, K. Nomura, I. Hashimoto, 2004, Archives of Dermatological Research.

Serum Anti-BPAG1 Auto-Antibody Is a Novel Marker for Human Melanoma

Y. Kaneda, K. Tamai, I. Katayama, 2010, PloS one.

Photoprotective effect of esterified glutathione against ultraviolet B-induced sunburn cell formation in the hairless mice.

K. Tamai, I. Hashimoto, K. Hanada, 1997, The Journal of investigative dermatology.

Longitudinal Single-Cell Transcriptomics Reveals a Role for Serpina3n-Mediated Resolution of Inflammation in a Mouse Colitis Model

Y. Kaneda, S. Takaki, K. Tamai, 2021, Cellular and molecular gastroenterology and hepatology.

Single-cell transcriptome analysis of a rat model of bilateral renal ischemia-reperfusion injury

N. Nonomura, K. Tamai, T. Shimbo, 2023, Biochemistry and biophysics reports.

Single-cell transcriptome analysis reveals cellular heterogeneity in mouse intra- and extra articular ligaments

K. Tamai, Y. Ishibashi, T. Shimbo, 2022, Communications Biology.

A study of the steroid sulfatase gene in families with X-linked ichthyosis using polymerase chain reaction.

K. Tamai, K. Nomura, I. Hashimoto, 1995, Acta dermato-venereologica.

Involvement of γ-secretase in postnatal angiogenesis

Y. Kaneda, R. Morishita, N. Sato, 2007 .

HIG1, a novel regulator of mitochondrial γ‐secretase, maintains normal mitochondrial function

Y. Kaneda, R. Morishita, N. Sato, 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Cancer Therapy : Preclinical Systemic Administration of a Novel Immune-Stimulatory Pseudovirion Suppresses Lung Metastatic Melanoma by Regionally Enhancing IFN-g Production

Y. Kaneda, K. Tamai, T. Yamazaki, 2013 .

Systemic Administration of a Novel Immune-Stimulatory Pseudovirion Suppresses Lung Metastatic Melanoma by Regionally Enhancing IFN-γ Production

Y. Kaneda, K. Tamai, T. Yamazaki, 2012, Clinical Cancer Research.

Infantile Perineal Protrusion: A Statistical, Clinical, and Histopathologic Study

K. Tamai, I. Hashimoto, Masaaki Takahashi, 2000, Dermatology.

Tissue-specific Expression of the 230-kDa Bullous Pemphigoid Antigen Gene (BPAG1)

J. Uitto, K. Tamai, H. Ishikawa, 1995, The Journal of Biological Chemistry.

Keratinocyte gene therapy: cytokine gene expression in local keratinocytes and in circulation by introducing cytokine genes into skin

K. Tamai, I. Hashimoto, K. Hanada, 2002, Experimental dermatology.

Identification of a DNA-binding protein (keratinocyte transcriptional protein-1) recognizing a keratinocyte-specific regulatory element in the 230-kDa bullous pemphigoid antigen gene.

J. Uitto, K. Tamai, K. Li, 1994, The Journal of biological chemistry.

PDGFRα‐lineage origin directs monocytes to trafficking proficiency to support peripheral immunity

K. Tamai, Eiichi Takaki, Yuya Ouchi, 2021, European journal of immunology.

Synthesized HMGB1 peptide attenuates liver inflammation and suppresses fibrosis in mice

S. Terai, M. Takamura, K. Tamai, 2021, Inflammation and Regeneration.

Japanese guidelines for diagnosis and treatment of junctional and dystrophic epidermolysis bullosa

K. Tamai, S. Imamura, I. Hashimoto, 2003, Archives of Dermatological Research.

Current status and future prospects of gene therapy technologies toward the treatment of intractable skin diseases

Y. Kaneda, K. Tamai, 2003, Archives of Dermatological Research.

Methyl-beta cyclodextrin alters the production and infectivity of Sendai virus

Y. Kaneda, K. Tamai, T. Shimbo, 2011, Archives of Virology.

Functional modification of Sendai virus by siRNA.

Y. Kaneda, K. Tamai, T. Shimbo, 2008, Journal of biotechnology.

Endogenous Mesenchymal Stromal Cells in Bone Marrow Are Required to Preserve Muscle Function in mdx Mice

Y. Kaneda, R. Fujita, K. Tamai, 2015, Stem cells.

Interferon‐γ down‐regulates expression of the 230‐kDa bullous pemphigoid antigen gene (BPAG1) in epidermal keratinocytes via novel chimeric sequences of ISRE and GAS

J. Uitto, K. Tamai, I. Hashimoto, 2006, Experimental dermatology.

A Rare Case of Atrophic Dermatofibroma Featuring Linear Skin Dimple

M. Fujimoto, K. Tamai, A. Tanemura, 2019, Case Reports in Dermatology.

Identification of cysteine residues involved in disulfide formation in the inactivation of glutathione transferase P-form by hydrogen peroxide.

S. Tsuchida, K. Tamai, K. Sato, 1993, Archives of biochemistry and biophysics.

Relation between the expression levels of the POU transcription factors Skn-1a and Skn-1n and keratinocyte differentiation.

K. Tamai, N. Umegaki, D. Sawamura, 2010, Journal of dermatological science.

Functional analysis of the nuclear localization signal of the POU transcription factor Skn‑1a in epidermal keratinocytes.

K. Tamai, D. Sawamura, H. Nakano, 2014, International journal of molecular medicine.

Vitamin D(3) inhibits expression of bullous pemphigoid antigen 1 through post-transcriptional mechanism without new protein synthesis.

K. Tamai, Y. Matsuzaki, D. Sawamura, 2008, Journal of dermatological science.

Identification of Skn-1n, a splice variant induced by high calcium concentration and specifically expressed in normal human keratinocytes.

J. Uitto, K. Tamai, T. Yamazaki, 2008, The Journal of investigative dermatology.

Cold shock domain protein A represses angiogenesis and lymphangiogenesis via inhibition of serum response element

Y. Kaneda, R. Morishita, H. Nakagami, 2008, Oncogene.

In vivo gene transfer method in keratinocyte gene therapy: intradermal injection of DNA complexed with high mobility group-1 protein in rats.

K. Tamai, I. Hashimoto, K. Hanada, 2000, Acta dermato-venereologica.

Synthesized HMGB1 peptide prevents the progression of inflammation, steatosis, fibrosis, and tumor occurrence in a non‐alcoholic steatohepatitis mouse model

S. Terai, K. Tamai, T. Shimbo, 2022, Hepatology research : the official journal of the Japan Society of Hepatology.

The combination of chemotherapy with HVJ-E containing Rad51 siRNA elicited diverse anti-tumor effects and synergistically suppressed melanoma

Y. Kaneda, K. Tamai, E. Kiyohara, 2011, Gene Therapy.

Case of Kindler syndrome resulting from mutation in the FERMT1 gene

J. McGrath, N. Katoh, K. Tamai, 2012, The Journal of dermatology.

Mallotus philippinensis bark extracts promote preferential migration of mesenchymal stem cells and improve wound healing in mice.

Y. Kaneda, K. Tamai, Shunya Sahara, 2014, Phytomedicine : international journal of phytotherapy and phytopharmacology.

Regulation of HN activity of HVJ with HN specific siRNA

Y. Kaneda, K. Tamai, T. Shimbo, 2006 .

Successful High-Dose Radiation Treatment for Chemo-Resistant Oral Squamous Cell Carcinoma in a Kindler's Syndrome Patient

M. Fujimoto, K. Tamari, K. Ogawa, 2021, Annals of dermatology.

Recurrent COL7A1 mutations in Japanese patients with dystrophic epidermolysis bullosa: positional effects of premature termination codon mutations on clinical severity. Japanese Collaborative Study Group on Epidermolysis Bullosa.

H. Shimizu, T. Nishikawa, J. Uitto, 1999, The Journal of investigative dermatology.

A Novel Quantitative Evaluation of Bone Formation After Opening Wedge High Tibial Osteotomy Using Tomosynthesis

K. Tamai, Y. Ishibashi, Y. Kimura, 2022, Journal of Digital Imaging.

Differential regulation of karyopherin alpha 2 expression by TGF-beta1 and IFN-gamma in normal human epidermal keratinocytes: evident contribution of KPNA2 for nuclear translocation of IRF-1.

Y. Kaneda, K. Tamai, I. Katayama, 2007, The Journal of investigative dermatology.

Karyopherin Alpha2 Is Essential for rRNA Transcription and Protein Synthesis in Proliferative Keratinocytes

T. Naka, K. Tamai, I. Katayama, 2013, PloS one.

Simultaneous and separated culture of keratinocytes and fibroblasts on each side of a collagen membrane.

K. Tamai, I. Hashimoto, Y. Mitsuhashi, 1993, Journal of dermatological science.

Transplanted Bone Marrow–Derived Circulating PDGFRα+ Cells Restore Type VII Collagen in Recessive Dystrophic Epidermolysis Bullosa Mouse Skin Graft

Y. Kaneda, M. Ishii, J. Uitto, 2015, The Journal of Immunology.

Immune Tolerance Induction Using Fetal Directed Placental Injection in Rodent Models: A Murine Model

H. Hosoda, A. Flake, K. Tamai, 2015, PloS one.

Laminin 5 genes and Herlitz junctional epidermolysis bullosa: novel mutations and polymorphisms in the LAMB3 and LAMC2 genes. Mutations in brief no. 190. Online.

J. Uitto, H. Tagami, L. Pulkkinen, 1998, Human mutation.

Systemic Circulation and Bone Recruitment of Osteoclast Precursors Tracked by Using Fluorescent Imaging Techniques

A. Miyawaki, Manato Kotani, M. Ishii, 2013, The Journal of Immunology.

Footprint-free gene mutation correction in induced pluripotent stem cell (iPSC) derived from recessive dystrophic epidermolysis bullosa (RDEB) using the CRISPR/Cas9 and piggyBac transposon system.

H. Nakagawa, H. Okano, K. Tamai, 2020, Journal of dermatological science.

179 Systemic administration of HMGB1 peptide drastically improves survival of the RDEB model mice by mobilizing multipotent stem/progenitor cells from bone marrow

Y. Kaneda, J. Uitto, K. Tamai, 2017 .

Systemic administration of HMGB1 peptide drastically improves survival of the RDEB model mice by mobilizing multipotent stem/progenitor cells from bone marrow.

K. Tamai, 2017 .

Modulation of class Pi glutathione transferase activity by sulfhydryl group modification.

S. Tsuchida, K. Tamai, K. Sato, 1991, Archives of biochemistry and biophysics.

Recent Advances in Clinical Research on Rare Intractable Hereditary Skin Diseases in Japan.

M. Akiyama, M. Amagai, K. Tamai, 2023, The Keio journal of medicine.

The compound heterozygote for new/recurrent COL7A1 mutations in a Japanese patient with bullous dermolysis of the newborn.

T. Hashimoto, K. Tamai, T. Hamada, 2009, Journal of dermatological science.

Compound heterozygosity for a nonsense mutation and a splice site mutation in the type VII collagen gene (COL7A1) in recessive dystrophic epidermolysis bullosa.

J. Uitto, J. McGrath, A. Christiano, 1997, Laboratory investigation; a journal of technical methods and pathology.

Gene-modified blister fluid-derived mesenchymal stromal cells for treating recessive dystrophic epidermolysis bullosa.

Y. Kaneda, K. Tamai, Y. Kikuchi, 2023, The Journal of investigative dermatology.

CROSS-TALK BETWEEN BONE MARROW AND TISSUE INJURY: NOVEL REGENERATIVE THERAPY FOR SEVERELY DAMAGED TISSUES BY MOBILIZING BONE MARROW MESENCHYMAL STEM CELLS IN VIVO

Y. Kaneda, K. Tamai, 2013 .

Keratinocyte responsive element 3: analysis of a keratinocyte-specific regulatory sequence in the 230-kDa bullous pemphigoid antigen gene promoter.

J. Uitto, K. Tamai, I. Hashimoto, 2003, The Journal of investigative dermatology.

Interferon--mediated Inactivation of Transcription of the 230-kDa Bullous Pemphigoid Antigen Gene (BPAG1) Provides Novel Insight into Keratinocyte Differentiation (*)

T. Nishikawa, J. Uitto, L. Rudnicka, 1995, The Journal of Biological Chemistry.

High-mobility group box-1 peptide ameliorates bronchopulmonary dysplasia by suppressing inflammation and fibrosis in a mouse model.

M. Fujii, K. Tamai, Tatsuo Masuda, 2021, Biochemical and biophysical research communications.

Dominant dystrophic epidermolysis bullosa caused by a novel G2037R mutation and by a known G2028R mutation in the type VII collagen gene (COL7A1)

K. Tamai, H. Nakano, Y. Tomita, 2006, The Journal of dermatology.

TGF-β1 Induces Fibroblast Proliferation Partly Through Actibation of RaF/MEK/ERK Signaling Pathway by Inhibition of RAF-KINASE Inhibitor Protein Expression

S. Tsuchida, K. Tamai, K. Hanada, 2016 .

Benefical Effects of Pioglitazone on Hypertensive Cardiac Hypertrophy in Adult Stroke-Prone Spontaneously Hypertensive Rats: P137

T. Ogihara, Y. Kaneda, R. Morishita, 2005 .

Cut-C: cleavage under tethered nuclease for conformational capture

Y. Kaneda, K. Tamai, T. Shimbo, 2019, BMC Genomics.

A Male Patient with Humoral Hypercalcemia of Malignancy (HHM) with Leukocytosis Caused by Cutaneous Squamous Cell Carcinoma Resulting from Recessive Dystrophic Epidermolysis Bullosa

Y. Etani, S. Kogaki, K. Ozono, 2011, Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology.

Enhanced elastin gene expression in chronically photodamaged skin: Localization of mRNAs by in situ hybridization and evidence for transcriptional activation of the gene by transient transfections with promoter/reporter gene constructs

J. Uitto, R. Tuan, Qiuhong Chen, 1993 .

Identification of transcription intiation site of the pemphigus vulgaris antigen gene and cell specificity of expression

J. Uitto, K. Tamai, Kehua Li, 1993 .

Molecular mechanisms of keratinocyte- and differentiation-specific expression of the 230-KDa bullous pemphigoid antigen gene (BPAG1)

J. Uitto, K. Tamai, Kehua Li, 1993 .

Transcriptional regulation of the 230‐kDa bullous pemphigoid antigen gene expression by interferon regulatory factor 1 and interferon regulatory factor 2 in normal human epidermal keratinocytes

K. Tamai, K. Hanada, Y. Kikuchi, 2004, Experimental dermatology.

Controlled induction of immune tolerance by mesenchymal stem cells transferred by maternal microchimerism.

K. Tamai, T. Shimbo, M. Endo, 2021, Biochemical and biophysical research communications.

Novel Autologous Cell Therapy in Ischemic Limb Disease Through Growth Factor Secretion by Cultured Adipose Tissue–Derived Stromal Cells

T. Ogihara, Y. Kaneda, R. Morishita, 2005, Arteriosclerosis, Thrombosis and Vascular Biology.

Molecular therapies for heritable blistering diseases.

Y. Kaneda, J. Uitto, K. Tamai, 2009, Trends in molecular medicine.

Hematopoietic and mesenchymal cell transplantation after myeloablative and non-myeloablative conditioning for recessive dystrophic and junctional epidermolysis bullosa (RDEB, JEB)

J. Tolar, J. McGrath, A. Hovnanian, 2012 .